Attention:

Certain features of Sigma-Aldrich.com will be down for maintenance the evening of Friday August 18th starting at 8:00 pm CDT until Saturday August 19th at 12:01 pm CDT.   Please note that you still have telephone and email access to our local offices. We apologize for any inconvenience.


Meet us at CRS 2017

July 16 - 19, 2017 in Boston, Massachussetts

Visit us at our new, vibrant booth #412 – 414

Control your drug delivery. Solutions from research to manufacturing.

EMD Millipore + Sigma-Aldrich come together to empower you to focus on your work with confidence, to solve the toughest problems in life science. We support our customers with best-in-class products for your lab, combined with technical expertise.

Meet our new MilliporeSigma team at booth 412 – 414 and learn about our latest products and complete portfolio for all stages of the drug manufacturing process, from academic R&D to industrial-scale production and quality control. Ask how our newest technologies will improve productivity, lower risks, reduce costs and promote safety. Together with you, MilliporeSigma is advancing bioproduction to accelerate development of therapeutic drugs for patients in need.

This year we will highlight:

Poster presentation topics include:

  • Michael Platscher: Solid Phase Synthesis of Active Targeting Lipids. A versatile, economic and scalable method to manufacture complex lipids for active targeting in high quality
  • Günter Moddelmog: Tailoring in-vitro drug release in solid dosage forms – a combination of PVA and HPMC
  • Günter Moddelmog: One strategy to address both solubility enhancement and controlled release: Polyvinyl alcohol for hot melt extrusion 
  • Prof. Banga: Development of avobenzone microsponge gel formulation using polyvinyl alcohol (Presenting author: Yang Song, Mercer University, USA)

Join our Workshop

Enabling Successful Liposomal Formulation from Scratch – Lipid Synthesis, CMC, Regulatory and Case Study.

Attend our joint premeeting workshop hosted by experts from MilliporeSigma, Polymun, CSO MiNA Therapeutics and the FDA. Their presentations will highlight the following topics: Process Development und GMP Manufacturing of Lipids; Lessons learned from liposomal products and processes – chemistry, manufacturing and controls; and Development of a small activating RNA (saRNA) encapsulated in a SMARTICLE® liposomal formulation for treatment of liver disease including Hepatocelluar cancer. 

July 16, 8 AM – 1 PM

Sheraton Boston Hotel, which connects directly to the Hynes Convention Center